EMEA-001039-PIP03-17
Key facts
| Invented name |
|
| Active substance |
Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0131/2018
|
| PIP number |
EMEA-001039-PIP03-17
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of hemifacial spasm
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Merz Pharmaceuticals GmbH
Tel.: +49 6915031 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|